Skip to main content
logo
HUTCHMED (China) Limited (AIM:HCM)
London flag London · Delayed Price · Currency is GBP · Price in GBX
258.00
+6.00 (2.38%)
Jul 18, 2025, 4:35 PM GMT+1

Revenue by Product

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
Oncology/Immunology - Research and Development
2.85B
Log In
Log In
Log In
Log In
Upgrade
Oncology/Immunology - Research and Development Growth
829.49%
Log In
Log In
Log In
Log In
Upgrade
Other Ventures
2.42B
Log In
Log In
Log In
Log In
Upgrade
Other Ventures Growth
17.81%
Log In
Log In
Log In
Log In
Upgrade
Oncology/Immunology - Marketed Products
1.29B
Log In
Log In
Log In
Log In
Upgrade
Oncology/Immunology - Marketed Products Growth
31.68%
Log In
Log In
Log In
Log In
Upgrade
Commercial Platform - Prescription Drugs
-
Log In
Log In
Log In
Log In
Upgrade
Commercial Platform - Prescription Drugs Growth
-
Log In
Log In
Log In
Log In
Upgrade
Commercial Platform - Consumer Health
-
Log In
Log In
Log In
Log In
Upgrade
Commercial Platform - Consumer Health Growth
-
Log In
Log In
Log In
Log In
Upgrade
Innovation Platform - Drug Research & Development
-
Log In
Log In
Log In
Log In
Upgrade
Innovation Platform - Drug Research & Development Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Year Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 NaN - NaN
China
3.80B
Log In
Log In
Log In
Log In
Upgrade
China Growth
13.69%
Log In
Log In
Log In
Log In
Upgrade
United States and Others
2.76B
Log In
Log In
Log In
Log In
Upgrade
Hong Kong
-
Log In
Log In
Log In
Log In
Upgrade
Hong Kong Growth
-
Log In
Log In
Log In
Log In
Upgrade